BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29339422)

  • 21. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
    Jen HL; Yin WH; Chen JW; Lin SJ
    J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
    Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
    J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective Effects of Palmitoleic Acid (C16:1n7) in a Mouse Model of Catecholamine-Induced Cardiac Damage Are Mediated by PPAR Activation.
    Betz IR; Qaiyumi SJ; Goeritzer M; Thiele A; Brix S; Beyhoff N; Grune J; Klopfleisch R; Greulich F; Uhlenhaut NH; Kintscher U; Foryst-Ludwig A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-lα in rats.
    Zhu ZY; Gao T; Huang Y; Xue J; Xie ML
    Food Funct; 2016 Apr; 7(4):1992-8. PubMed ID: 26987380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial Disruption Is Involved in the Effect of Nuclear Factor of Activated T cells, Cytoplasmic 4 on Aggravating Cardiomyocyte Hypertrophy.
    Liu X; Gao S; Gao H; Jiang X; Wei Q
    J Cardiovasc Pharmacol; 2021 May; 77(5):557-569. PubMed ID: 33951694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
    Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
    Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Miro1 as a novel regulator of hypertrophy in neonatal rat cardiomyocytes.
    Conejeros C; Parra V; Sanchez G; Pedrozo Z; Olmedo I
    J Mol Cell Cardiol; 2020 Apr; 141():65-69. PubMed ID: 32234389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models.
    Ozakca I
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.
    Pang T; Gan XT; Freeman DJ; Cook MA; Karmazyn M
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H545-53. PubMed ID: 19966059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fish oil constituent eicosapentaenoic acid inhibits endothelin-induced cardiomyocyte hypertrophy via PPAR-α.
    Shimojo N; Jesmin S; Sakai S; Maeda S; Miyauchi T; Mizutani T; Aonuma K; Kawano S
    Life Sci; 2014 Nov; 118(2):173-8. PubMed ID: 24792520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secreted Factors from Adipose Tissue Reprogram Tumor Lipid Metabolism and Induce Motility by Modulating PPARα/ANGPTL4 and FAK.
    Blücher C; Iberl S; Schwagarus N; Müller S; Liebisch G; Höring M; Hidrobo MS; Ecker J; Spindler N; Dietrich A; Burkhardt R; Stadler SC
    Mol Cancer Res; 2020 Dec; 18(12):1849-1862. PubMed ID: 32859692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between apoptosis and alteration of the energetic metabolism pathways of hypertrophic cardiomyocytes induced by hypoxia-reoxygenation].
    Feng B; Liu W; Xu J; He ZY; Yang HB
    Sheng Li Xue Bao; 2005 Oct; 57(5):636-42. PubMed ID: 16220203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.
    Staiger H; Haas C; Machann J; Werner R; Weisser M; Schick F; Machicao F; Stefan N; Fritsche A; Häring HU
    Diabetes; 2009 Mar; 58(3):579-89. PubMed ID: 19074989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro.
    Autelitano DJ; Ridings R; Tang F
    Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
    Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
    Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice
    Cai Y; Liu H; Song E; Wang L; Xu J; He Y; Zhang D; Zhang L; Cheng KK; Jin L; Wu M; Liu S; Qi D; Zhang L; Lopaschuk GD; Wang S; Xu A; Xia Z
    Theranostics; 2021; 11(10):4710-4727. PubMed ID: 33754023
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
    Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
    Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
    Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.